DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC SHOCK"
$2,999,999
| Recipient | ZYMERON CORPORATION UEI GAMMMRQ6QMN1 |
|---|---|
| Award ID | HT942523C0067 |
| Award amount | $2,999,999 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Defense — Defense Health Agency |
| NAICS | 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| PSC | AN12 |
| Start date | Sep 15, 2023 |
| End date | Jan 14, 2026 |
| Place of performance | DURHAM, NC |
| Record updated | Aug 7, 2026 |
View the official award record
More awards won by ZYMERON CORPORATION
AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "DEVELOPMENT FOR A NOVEL COUNTERMEASURE, RADIODEFENDER, AS A RADIOPROTECTOR FOR HEMATOPOIETIC ACUTE RADIATION SYNDROME"
Department of Defense · $2,999,993 · Feb 7, 2022
DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS
Department of Defense · $2,999,983 · Sep 20, 2024
COMPLETE SBIR TOPIC 46 PHASE II TASKS
Department of Health and Human Services · $1,500,000 · Aug 1, 2019
RAPID POINT OF CARE TESTS TO SIMULTANEOUSLY QUANTIFY ANTI-TB DRUGS IN BLOOD.
Department of Health and Human Services · $1,272,000 · Aug 12, 2021
AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "NOVEL ANTIBIOTICS TARGETING MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA INFECTIONS"
Department of Defense · $1,100,000 · Jul 11, 2022
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids